Results 91 to 100 of about 1,706,119 (221)

Updated Scientific Opinion on the risks for animal and human health related to the presence of phomopsins in feed and food

open access: yesEFSA Journal, Volume 24, Issue 11, November 2026.
Abstract The EFSA CONTAM Panel assessed the risks for animal and human health related to the presence of phomopsins in feed and food. Lupins are considered the main source of phomopsins. Since the previous CONTAM Panel 2012 Opinion on phomopsins, new studies investigated the structural diversity of phomopsins.
EFSA Panel on Contaminants in the Food Chain (CONTAM)   +28 more
wiley   +1 more source

3D-QSAR-Assisted Design, Synthesis, and Evaluation of Novobiocin Analogues

open access: yes, 2013
Hsp90 is an attractive therapeutic target for the treatment of cancer. Extensive structural modifications to novobiocin, the first Hsp90 C-terminal inhibitor discovered, have produced a library of novobiocin analogues and revealed some structure ...
Blagg, Brian S. J.   +9 more
core   +1 more source

The integration of pharmacophore-based 3D QSAR modeling and virtual screening in safety profiling: A case study to identify antagonistic activities against adenosine receptor, A2A, using 1,897 known drugs.

open access: yesPLoS ONE, 2019
Safety pharmacology screening against a wide range of unintended vital targets using in vitro assays is crucial to understand off-target interactions with drug candidates.
Fan Fan   +3 more
doaj   +1 more source

3D-QSAR studies on Maslinic acid analogs for Anticancer activity against Breast Cancer cell line MCF-7

open access: yesScientific Reports, 2017
Global prevalence of breast cancer and its rising frequency makes it a key area of research in drug discovery programs. The research article describes the development of field based 3D-QSAR model based on human breast cancer cell line MCF7 in vitro ...
Sarfaraz Alam, Feroz Khan
doaj   +1 more source

A Review of 3D-QSAR in Drug Design [PDF]

open access: yesJournal of the Chosun Natural Science, 2012
Quantitative structure-activity relationship (QSAR) methodologies have been applied for many years, to correlate the relationship between physicochemical properties of chemical substances and their biological activities to generate a statistical model for prediction of the activities of new chemical entities.
openaire   +1 more source

3D-QSAR and Docking Studies of a Series of β-Carboline Derivatives as Antitumor Agents of PLK1

open access: yesJournal of Chemistry, 2014
An alignment-free, three dimensional quantitative structure-activity relationship (3D-QSAR) analysis has been performed on a series of β-carboline derivatives as potent antitumor agents toward HepG2 human tumor cell lines.
Jahan B. Ghasemi, Valentin Davoudian
doaj   +1 more source

3D-QSAR studies of checkpoint kinase 1 inhibitors based on molecular docking and CoMFA

open access: yes, 2010
Three-dimensional quantitative structure–activity relationship (3D-QSAR) studies were performed on a series of substituted 1,4-dihydroindeno[1,2-c]pyrazoles inhibitors, using molecular docking and comparative molecular field analysis (CoMFA). The docking
X. Ma (1721764)   +4 more
core  

Cytotoxicity, 2D-and 3D-QSAR Study of some Halogen Containing Hydroxy and Amino Substituted Aromatic Compounds

open access: yes, 2020
A set of 24 halogen containing hydroxy and amino substituted aromatic compounds were subjected to 2D-and 3D-QSAR studies. 3D-QSAR was studied at a 2.0 Ǻ 3D grid spacing using molecular interaction fields (MIFs) analysis.
M Idrish Ali, M Abul, Kashem Liton
core  

N-Phenyl-3-sulfamoyl-benzamide derivatives as anti-hepatitis B virus agent candidates. Integrated computational studies [PDF]

open access: yesJournal of the Serbian Chemical Society
This study used a combined approach of atom-based 3D-QSAR modeling and molecular docking to investigate 44 N-phenyl-3-sulfamoyl-benzamide derivatives as potential inhibitors of the hepatitis B virus (HBV).
Laoud Aicha   +2 more
doaj   +1 more source

3D-QSAR-Assisted Design, Synthesis, and Evaluation of Novobiocin Analogues

open access: yes, 2016
Hsp90 is an attractive therapeutic target for the treatment of cancer. Extensive structural modifications to novobiocin, the first Hsp90 C-terminal inhibitor discovered, have produced a library of novobiocin analogues and revealed some structure–activity
Giorgio Colombo (65952)   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy